Aceragen Inc (ACGN) Quote

ACGN new 52 week low

$ACGN - 🚀Up 7.3% Pre-Market/ Current Price $0.54
Delisting from The Nasdaq Stock Market
and appears to be being removed from ALL Markets permanently.

ACGN new 52 week low

Price to tangible book is .20 I've never seen this before Do your own DD

$50 million,partnership with Department of Defense’s,Defense Threat Reduction Agency (“DTRA”) to investigate ACG-701 as a potential medical countermeasure for melioidosis, a life-threatening infection caused by the B. pseudomallei pathogen. This program is centered around a Phase 2 trial, the TERRA study (NCT05105035), which is a randomized double-blind, placebo-controlled trial conducted in hospitalized melioidosis patients.

2.62M float,3.66M o/s,short .02M,book pps $3.23,cash/share $1.25,target $17.00,sales $4.86M,26 employees,insiders 8.6%,institutions 5.6%,volitility 16%-23%,shares available to short dropped 500% this morning,(still 1000 since 8am) <great sign of rebound,could go to ZERO BORROW soon,above ave buying vol.,accumulation started fri.